Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 2 |
| Jun 2026 | 1 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2021 Filed Mar 9, 2021 23:08 UTC |
Horgen Jay C.Director · President and CEO
|
GrantStock Units · Derivative | 47,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009927 · form4.xml · derivative · entry 4 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,988 Underlying: Common Stock · 47,988 shares Expires not disclosed F3 · derivative.exercise_price: Reflects the initial tranche of a restricted stock unit award granted in August 2019, which vests on August 15, 2021 following the satisfaction of applicable performance conditions previously described in the Company's annual meeting proxy statements. F3 · derivative.exercise_date: Reflects the initial tranche of a restricted stock unit award granted in August 2019, which vests on August 15, 2021 following the satisfaction of applicable performance conditions previously described in the Company's annual meeting proxy statements. F3 · derivative.expiration_date: Reflects the initial tranche of a restricted stock unit award granted in August 2019, which vests on August 15, 2021 following the satisfaction of applicable performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 23:08 UTC |
Horgen Jay C.Director · President and CEO
|
Tax withholdingCommon Stock | 7,778 | $139.31 | $1,083,553.18 |
DisclosureSEC source: 0001127602-21-009927 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,546 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the settlement of the awards described above. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 23:08 UTC |
Horgen Jay C.Director · President and CEO
|
GrantCommon Stock | 19,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009927 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,324 F1 · shares: Awards granted in January 2017 and 2018, which settled following the achievement of performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 23:06 UTC |
Wojcik Thomas MChief Financial Officer
|
GrantStock Units · Derivative | 5,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009926 · form4.xml · derivative · entry 2 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,958 Underlying: Common Stock · 5,958 shares Expires not disclosed F2 · derivative.exercise_price: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: The award, issued under the Company's 2020 Equity Incentive Plan, vests in four equal installments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 23:06 UTC |
Wojcik Thomas MChief Financial Officer
|
GrantStock Units · Derivative | 4,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009926 · form4.xml · derivative · entry 1 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,922 Underlying: Common Stock · 4,922 shares Expires not disclosed F1 · derivative.exercise_price: Reflects the initial tranche of a restricted stock unit award granted in August 2019, which vests on August 15, 2021 following the satisfaction of applicable performance conditions previously described in the Company's annual meeting proxy statements. F1 · derivative.exercise_date: Reflects the initial tranche of a restricted stock unit award granted in August 2019, which vests on August 15, 2021 following the satisfaction of applicable performance conditions previously described in the Company's annual meeting proxy statements. F1 · derivative.expiration_date: Reflects the initial tranche of a restricted stock unit award granted in August 2019, which vests on August 15, 2021 following the satisfaction of applicable performance conditions previously described in the Company's annual meeting proxy statements. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 13:29 UTC |
Jeffery Reuben IIIDirector
|
PurchaseCommon Stock | 2,500 | $145.53 | $363,825.00 |
DisclosureSEC source: 0001127602-21-005101 · form4.xml · nonDerivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F1 · price: Reflects the price paid for shares purchased on the open market. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 13:30 UTC |
Horgen Jay C.Director · President and CEO
|
PurchaseCommon Stock | 4,000 | $136.23 | $544,920.00 |
DisclosureSEC source: 0001127602-21-004799 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,026 F1 · price: The price reflects the weighted average price of shares purchased on the open market; the individual transaction prices ranged from $136.00 to $137.67. Specific transaction details will be provided to the SEC upon request. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:52 UTC |
Matos Rodriguez Felix V.Director
|
GrantStock Units · Derivative | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004740 · form4.xml · derivative · entry 2 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833 Underlying: Common Stock · 833 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:52 UTC |
Matos Rodriguez Felix V.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 636 | $0.00 Strike: $132.10 | $0.00 |
DisclosureSEC source: 0001127602-21-004740 · form4.xml · derivative · entry 1 Matos Rodriguez Felix V. · CIK 0001838275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636 Underlying: Common Stock · 636 shares Expires 2028-02-08 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:49 UTC |
Jeffery Reuben IIIDirector
|
GrantStock Units · Derivative | 985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004733 · form4.xml · derivative · entry 2 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 985 Underlying: Common Stock · 985 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:49 UTC |
Jeffery Reuben IIIDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 636 | $0.00 Strike: $132.10 | $0.00 |
DisclosureSEC source: 0001127602-21-004733 · form4.xml · derivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636 Underlying: Common Stock · 636 shares Expires 2028-02-08 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:50 UTC |
Churchill Dwight D.Director
|
GrantStock Units · Derivative | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004735 · form4.xml · derivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,458 Underlying: Common Stock · 1,458 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:50 UTC |
Churchill Dwight D.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 636 | $0.00 Strike: $132.10 | $0.00 |
DisclosureSEC source: 0001127602-21-004735 · form4.xml · derivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636 Underlying: Common Stock · 636 shares Expires 2028-02-08 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:48 UTC |
Atkinson Tracy ADirector
|
GrantStock Units · Derivative | 909 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004727 · form4.xml · derivative · entry 2 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 909 Underlying: Common Stock · 909 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:48 UTC |
Atkinson Tracy ADirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 636 | $0.00 Strike: $132.10 | $0.00 |
DisclosureSEC source: 0001127602-21-004727 · form4.xml · derivative · entry 1 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636 Underlying: Common Stock · 636 shares Expires 2028-02-08 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:46 UTC |
Alvingham Karen L.Director
|
GrantStock Units · Derivative | 883 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004724 · form4.xml · derivative · entry 2 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 883 Underlying: Common Stock · 883 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:46 UTC |
Alvingham Karen L.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 636 | $0.00 Strike: $132.10 | $0.00 |
DisclosureSEC source: 0001127602-21-004724 · form4.xml · derivative · entry 1 Alvingham Karen L. · CIK 0001726148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636 Underlying: Common Stock · 636 shares Expires 2028-02-08 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:44 UTC |
Palandjian Tracy P.Director
|
GrantStock Units · Derivative | 954 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004721 · form4.xml · derivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 954 Underlying: Common Stock · 954 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:44 UTC |
Palandjian Tracy P.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 636 | $0.00 Strike: $132.10 | $0.00 |
DisclosureSEC source: 0001127602-21-004721 · form4.xml · derivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636 Underlying: Common Stock · 636 shares Expires 2028-02-08 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of March 5, 2022, 2023, 2024 and 2025. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:22 UTC |
Billings David M.General Counsel and Secretary
|
Exercise / conversionStock Units · Derivative | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000751 · form4.xml · derivative · entry 3 Billings David M. · CIK 0001611537 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,217 Underlying: Common Stock · 609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F1 · derivative.exercise_date: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F1 · derivative.expiration_date: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F2 · balance_after: 1,387 restricted stock units (RSUs) previously reported as common stock are now being reported in Table II as derivative securities. The RSUs vest from 2022 to 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:22 UTC |
Billings David M.General Counsel and Secretary
|
Tax withholdingCommon Stock | 973 | $101.70 | $98,954.10 |
DisclosureSEC source: 0001127602-21-000751 · form4.xml · nonDerivative · entry 2 Billings David M. · CIK 0001611537 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,063 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of previously reported awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:22 UTC |
Billings David M.General Counsel and Secretary
|
Exercise / conversionCommon Stock | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000751 · form4.xml · nonDerivative · entry 1 Billings David M. · CIK 0001611537 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F2 · balance_after: 1,387 restricted stock units (RSUs) previously reported as common stock are now being reported in Table II as derivative securities. The RSUs vest from 2022 to 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:24 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionStock Units · Derivative | 5,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000759 · form4.xml · derivative · entry 4 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,523 Underlying: Common Stock · 5,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F1 · derivative.exercise_date: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F1 · derivative.expiration_date: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F2 · balance_after: 8,147 restricted stock units (RSUs) previously reported as common stock are now being reported in Table II as derivative securities. The RSUs vest from 2022 to 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:24 UTC |
Horgen Jay C.Director · President and CEO
|
Tax withholdingCommon Stock | 8,286 | $101.70 | $842,686.20 |
DisclosureSEC source: 0001127602-21-000759 · form4.xml · nonDerivative · entry 2 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,026 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of previously reported awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:24 UTC |
Horgen Jay C.Director · President and CEO
|
Exercise / conversionCommon Stock | 5,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000759 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F2 · balance_after: 8,147 restricted stock units (RSUs) previously reported as common stock are now being reported in Table II as derivative securities. The RSUs vest from 2022 to 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:07 UTC |
Earle GlennDirector
|
Exercise / conversionStock Units · Derivative | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000699 · form4.xml · derivative · entry 3 Earle Glenn · CIK 0001639226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,630 Underlying: Common Stock · 559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:07 UTC |
Earle GlennDirector
|
Tax withholdingCommon Stock | 43 | $101.70 | $4,373.10 |
DisclosureSEC source: 0001127602-21-000699 · form4.xml · nonDerivative · entry 2 Earle Glenn · CIK 0001639226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,113 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of previously reported awards. F3 · balance_after: Balance includes seven shares of common stock acquired as a result of dividend accruals on previously vested restricted stock unit awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:07 UTC |
Earle GlennDirector
|
Exercise / conversionCommon Stock | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000699 · form4.xml · nonDerivative · entry 1 Earle Glenn · CIK 0001639226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:13 UTC |
Churchill Dwight D.Director
|
Exercise / conversionStock Units · Derivative | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000722 · form4.xml · derivative · entry 2 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,561 Underlying: Common Stock · 559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:13 UTC |
Churchill Dwight D.Director
|
Exercise / conversionCommon Stock | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000722 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F2 · balance_after: Balance includes seven shares of common stock acquired as a result of dividend accruals on previously vested restricted stock unit awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:18 UTC |
Wojcik Thomas MChief Financial Officer
|
Exercise / conversionStock Units · Derivative | 2,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000737 · form4.xml · derivative · entry 3 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,041 Underlying: Common Stock · 2,642 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F1 · derivative.exercise_date: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F1 · derivative.expiration_date: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F2 · balance_after: 11,115 restricted stock units (RSUs) previously reported as common stock are now being reported in Table II as derivative securities. The RSUs vest from 2022 to 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:18 UTC |
Wojcik Thomas MChief Financial Officer
|
Tax withholdingCommon Stock | 6,785 | $101.70 | $690,034.50 |
DisclosureSEC source: 0001127602-21-000737 · form4.xml · nonDerivative · entry 2 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,239 F3 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of previously reported awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:18 UTC |
Wojcik Thomas MChief Financial Officer
|
Exercise / conversionCommon Stock | 2,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000737 · form4.xml · nonDerivative · entry 1 Wojcik Thomas M · CIK 0001776685 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of a previously reported award. The award vests in four equal installments on each of January 1, 2021, 2022, 2023 and 2024. F2 · balance_after: 11,115 restricted stock units (RSUs) previously reported as common stock are now being reported in Table II as derivative securities. The RSUs vest from 2022 to 2023. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:09 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionStock Units · Derivative | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000707 · form4.xml · derivative · entry 2 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,809 Underlying: Common Stock · 559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:09 UTC |
Palandjian Tracy P.Director
|
Exercise / conversionCommon Stock | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000707 · form4.xml · nonDerivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F2 · balance_after: Balance includes seven shares of common stock acquired as a result of dividend accruals on previously vested restricted stock unit awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:04 UTC |
Alvingham Karen L.Director
|
Exercise / conversionStock Units · Derivative | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000687 · form4.xml · derivative · entry 3 Yerburgh Karen · CIK 0001726148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,423 Underlying: Common Stock · 439 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.exercise_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. F1 · derivative.expiration_date: Reflects the vesting of previously reported awards. Awards vest 2018-2024. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:04 UTC |
Alvingham Karen L.Director
|
Tax withholdingCommon Stock | 34 | $101.70 | $3,457.80 |
DisclosureSEC source: 0001127602-21-000687 · form4.xml · nonDerivative · entry 2 Yerburgh Karen · CIK 0001726148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807 F2 · shares: Reflects the automatic surrender of shares of common stock to the Company to satisfy tax withholding obligations related to the vesting of previously reported awards. F3 · balance_after: Balance includes four shares of common stock acquired as a result of dividend accruals on previously vested restricted stock unit awards. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:04 UTC |
Alvingham Karen L.Director
|
Exercise / conversionCommon Stock | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000687 · form4.xml · nonDerivative · entry 1 Yerburgh Karen · CIK 0001726148 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Reflects the vesting of previously reported awards. Awards vest 2018-2024. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 21:04 UTC |
Churchill Dwight D.Director
|
GrantStock Units · Derivative | 761 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027663 · form4.xml · derivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761 Underlying: Common Stock · 761 shares Expires not disclosed F1 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 21:06 UTC |
Atkinson Tracy ADirector
|
GrantStock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027665 · form4.xml · derivative · entry 2 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,042 Underlying: Common Stock · 1,042 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 21:06 UTC |
Atkinson Tracy ADirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 2,029 | $0.00 Strike: $76.89 | $0.00 |
DisclosureSEC source: 0001127602-20-027665 · form4.xml · derivative · entry 1 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,029 Underlying: Common Stock · 2,029 shares Expires 2027-10-27 F1 · derivative.exercise_date: This option is exercisable in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 21:03 UTC |
Earle GlennDirector
|
GrantStock Units · Derivative | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027660 · form4.xml · derivative · entry 1 Earle Glenn · CIK 0001639226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85 Underlying: Common Stock · 85 shares Expires not disclosed F1 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 21:01 UTC |
Jeffery Reuben IIIDirector
|
GrantStock Units · Derivative | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027659 · form4.xml · derivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 Underlying: Common Stock · 20 shares Expires not disclosed F1 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. Read SEC document |
| October 27, 2020 Filed Oct 29, 2020 20:59 UTC |
Palandjian Tracy P.Director
|
GrantStock Units · Derivative | 124 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-027656 · form4.xml · derivative · entry 1 Palandjian Tracy P. · CIK 0001543889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124 Underlying: Common Stock · 124 shares Expires not disclosed F1 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. F1 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of January 1, 2022, 2023, 2024 and 2025. Read SEC document |
| September 15, 2020 Filed Sep 15, 2020 20:41 UTC |
Churchill Dwight D.Director
|
PurchaseCommon Stock | 1,000 | $65.25 | $65,250.00 |
DisclosureSEC source: 0001127602-20-025113 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,069 F1 · price: Reflects the price paid for shares purchased on the open market. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 12:06 UTC |
Atkinson Tracy ADirector
|
PurchaseCommon Stock | 1,469 | $68.46 | $100,567.74 |
DisclosureSEC source: 0001127602-20-024864 · form4.xml · nonDerivative · entry 1 Atkinson Tracy A · CIK 0001338351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,469 Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 12:01 UTC |
Jeffery Reuben IIIDirector
|
PurchaseCommon Stock | 5,000 | $70.16 | $350,800.00 |
DisclosureSEC source: 0001127602-20-024771 · form4.xml · nonDerivative · entry 1 Jeffery Reuben III · CIK 0001492280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reflects the weighted average price of shares purchased on the open market; the individual transaction prices ranged from $69.65 to $71.66. Specific transaction details will be provided to the SEC upon request. Read SEC document |
| September 03, 2020 Filed Sep 3, 2020 20:35 UTC |
Churchill Dwight D.Director
|
PurchaseCommon Stock | 1,000 | $71.99 | $71,990.00 |
DisclosureSEC source: 0001127602-20-024710 · form4.xml · nonDerivative · entry 1 Churchill Dwight D. · CIK 0001486072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,069 F1 · price: Reflects the price paid for shares purchased on the open market. Read SEC document |
| September 01, 2020 Filed Sep 1, 2020 21:10 UTC |
Horgen Jay C.Director · President and CEO
|
PurchaseCommon Stock | 5,000 | $67.90 | $339,500.00 |
DisclosureSEC source: 0001127602-20-024577 · form4.xml · nonDerivative · entry 1 Horgen Jay C. · CIK 0001432993 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,667 F1 · price: The price reflects the weighted average price of shares purchased on the open market; the individual transaction prices ranged from $67.44 to $68.35. Specific transaction details will be provided to the SEC upon request. Read SEC document |
| July 28, 2020 Filed Jul 31, 2020 00:08 UTC |
Byrne Samuel TDirector
|
GrantStock Units · Derivative | 2,342 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022344 · form4.xml · derivative · entry 2 Byrne Samuel T · CIK 0001474915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,342 Underlying: Common Stock · 2,342 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of August 15, 2021, 2022, 2023 and 2024. F2 · derivative.exercise_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of August 15, 2021, 2022, 2023 and 2024. F2 · derivative.expiration_date: Each stock unit represents a right to receive one share of the Company's common stock upon vesting. The stock units vest in 25% increments on each of August 15, 2021, 2022, 2023 and 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.